日本語View as Markdown

Molecular hydrogen protects human lymphocyte AHH-1 cells against 12C6+ heavy ion radiation.

分子状水素による重粒子線(¹²C⁶⁺)照射からのヒトリンパ球AHH-1細胞の保護効果

in vitro study in vitro positive

Abstract

This in vitro study examined whether molecular hydrogen (H2) could protect human lymphocyte AHH-1 cells from damage caused by 12C6+ heavy ion radiation, a hazard relevant to both space travel and heavy ion cancer irradiation. H2-saturated RPMI 1640 medium was prepared under 0.4 MPa pressure. Intracellular reactive oxygen species (ROS) were quantified using HPF probe and H2DCFH-DA fluorescent dye. Apoptosis was assessed by Annexin V-FITC/propidium iodide double staining and Hoechst 33342 staining, cell cycle distribution by PI staining, and apoptosis-related protein expression by Western blot. H2 reduced ROS levels both in irradiated cells and in water radiolysis. It also diminished radiation-induced apoptosis, relieved G2/M cell cycle arrest, and suppressed Caspase 3 activation. These findings suggest H2 exerts radioprotective effects by lowering oxidative stress and modulating apoptotic signaling pathways.

Mechanism

H2 scavenges intracellular ROS generated by heavy ion radiation, thereby suppressing Caspase 3 activation, reducing G2/M cell cycle arrest, and attenuating apoptosis in irradiated lymphocytes.

Bibliographic

Authors
Yang Y, Gao F, Zhang H, Hunag Y, Zhang P, Liu C, et al.
Journal
Int J Radiat Biol
Year
2013
PMID
23786587
DOI
10.3109/09553002.2013.817704

Tags

Disease:がん放射線療法 (副作用軽減) Mechanism:アポトーシス抑制 ヒドロキシルラジカル消去 免疫調節 酸化ストレス 活性酸素種

Delivery context

This is basic research at the cellular or molecular level. For human application, inhalation is the most promising delivery route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration devices are not recommended).

Safety notes

This is basic research at the cellular or molecular level. For human application, inhalation is the most promising delivery route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 23786587. https://h2-papers.org/en/papers/23786587
Source: PubMed PMID 23786587